1. Home
  2. CDTG vs MRNS Comparison

CDTG vs MRNS Comparison

Compare CDTG & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDTG
  • MRNS
  • Stock Information
  • Founded
  • CDTG 2012
  • MRNS 2003
  • Country
  • CDTG China
  • MRNS United States
  • Employees
  • CDTG N/A
  • MRNS N/A
  • Industry
  • CDTG
  • MRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CDTG
  • MRNS Health Care
  • Exchange
  • CDTG NYSE
  • MRNS Nasdaq
  • Market Cap
  • CDTG 34.6M
  • MRNS 29.9M
  • IPO Year
  • CDTG 2024
  • MRNS 2014
  • Fundamental
  • Price
  • CDTG $1.40
  • MRNS $0.55
  • Analyst Decision
  • CDTG
  • MRNS Buy
  • Analyst Count
  • CDTG 0
  • MRNS 12
  • Target Price
  • CDTG N/A
  • MRNS $4.28
  • AVG Volume (30 Days)
  • CDTG 239.4K
  • MRNS 1.5M
  • Earning Date
  • CDTG 04-03-2025
  • MRNS 03-04-2025
  • Dividend Yield
  • CDTG N/A
  • MRNS N/A
  • EPS Growth
  • CDTG N/A
  • MRNS N/A
  • EPS
  • CDTG 0.72
  • MRNS N/A
  • Revenue
  • CDTG $31,432,824.00
  • MRNS $31,466,000.00
  • Revenue This Year
  • CDTG N/A
  • MRNS $14.97
  • Revenue Next Year
  • CDTG N/A
  • MRNS $57.65
  • P/E Ratio
  • CDTG $1.66
  • MRNS N/A
  • Revenue Growth
  • CDTG N/A
  • MRNS 1.63
  • 52 Week Low
  • CDTG $1.16
  • MRNS $0.22
  • 52 Week High
  • CDTG $4.64
  • MRNS $10.50
  • Technical
  • Relative Strength Index (RSI)
  • CDTG N/A
  • MRNS 70.09
  • Support Level
  • CDTG N/A
  • MRNS $0.54
  • Resistance Level
  • CDTG N/A
  • MRNS $0.55
  • Average True Range (ATR)
  • CDTG 0.00
  • MRNS 0.01
  • MACD
  • CDTG 0.00
  • MRNS -0.01
  • Stochastic Oscillator
  • CDTG 0.00
  • MRNS 93.00

About CDTG CDT ENVIRONMENTAL TECH INV HLDG LTD

CDT Environmental Technology Investment Holdings Ltd is a waste treatment company. The company generates revenue through the design, development, manufacture, sales, installation, operation and maintenance of sewage treatment systems and by providing sewage treatment services. It engages in two business lines namely, rural sewage treatment and septic tank treatment in both urban and rural areas.

About MRNS Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

Share on Social Networks: